| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |